Scientific and development research
HiPep Laboratories
HiPep Laboratories
The company‘s core technology is based on the founder’s many years of fundamental research achievements in multiple fields (synthetic chemistry, analytical science, engineering, medicine, and pharmaceutical sciences) both in Japan and overseas.
The main theme of R&D is "next-generation healthcare technology," and the following four basic technologies have recently been completed.
Innovative bioinstrumentation and diagnostic systems using next-generation biochips based on novel principles:
① PepTenChip® system
② Production technology for pyrrole-imidazole peptide (PIPA), a gene-regulating drug with a novel mechanism of action (Production and sale of telomere visualization probes as an example of application)
③ Regenerative medicine and angiogenic peptides (AGP) and their complexes
④ One Peptide on One Bead library, a drug discovery tool (expected to compensate for the shortcomings of nucleic acid-encoding display system).
All of these technologies are currently under further development for practical use, and collaboration and licensing out of technologies are being considered in order to raise funds for licensing approval.
Area of Interest
Site-visit
SDGs we are working on
Registered Keyword
The main theme of R&D is "next-generation healthcare technology," and the following four basic technologies have recently been completed.
Innovative bioinstrumentation and diagnostic systems using next-generation biochips based on novel principles:
① PepTenChip® system
② Production technology for pyrrole-imidazole peptide (PIPA), a gene-regulating drug with a novel mechanism of action (Production and sale of telomere visualization probes as an example of application)
③ Regenerative medicine and angiogenic peptides (AGP) and their complexes
④ One Peptide on One Bead library, a drug discovery tool (expected to compensate for the shortcomings of nucleic acid-encoding display system).
All of these technologies are currently under further development for practical use, and collaboration and licensing out of technologies are being considered in order to raise funds for licensing approval.
Area of Interest
- North America
- Europe
- Southeast Asia
- China
Site-visit
Allowed or subject to conditions
SDGs we are working on
3.Good health and well-being
9.Industry, innovation, infrastructure
12.Responsible consumption, production
Registered Keyword
HiPep Laboratories was founded focusing on 'industrial applications of biofunctions and molecular recognitions'. The core technology is mimicking biomolecules by peptide derivatives, syntheses, characterization and applications. Diagnostics using peptide microarrays, chips and detecting devices were commercialized. In addition to protein recognition, the industrial production of DNA recognition molecules using peptides based on pyrrole and imidazole was completed. Cyclic peptide immobilized libraries and drug delivery technologies (peptide vehicles) have also been developed. The company manufactures and sells equipment and related consumables originally developed for in-house use. The company also provides contract services and consultancy, using full use of its extensive facilities with expertise.